A Non-Canonical Aryl Hydrocarbon Receptor Pathway Authorizes and Safeguards Clinical-Scale Expansion of Functional Human Endothelial Cells

The authors identified a non-canonical aryl hydrocarbon receptor pathway switched on by canonical AHR inhibitors that reactivates quiescent endothelial cell proliferation.